|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
8 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Formation and operating costs | |||||
| Government grant revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expenses) | |||||
| Interest income earned on investments held in trust account | |||||
| Change in fair value of convertible note | |||||
| Loss on change in the fair value of convertible notes | |||||
| Gain on the change in fair value of warrant liabilities | |||||
| Loss on the change in fair value of digital assets | |||||
| Interest expense (including related parties amounts of $1,330 and $2,400 for the years ended December 31, 2025 and 2024, respectively) | |||||
| Financing costs | |||||
| Other income | |||||
| Total other expense, net | |||||
| (Loss) income before provision for income tax | |||||
| Income tax provision | |||||
| Net loss | |||||
| Net loss per share, basic (in Dollars per share) | |||||
| Common stock subject to possible redemption | |||||
| Total net loss per share, basic (in Dollars per share) | |||||
| Net loss per share, diluted (in Dollars per share) | |||||
| Common stock subject to possible redemption | |||||
| Total net loss per share, diluted (in Dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in Shares) | |||||
| Common stock subject to possible redemption | |||||
| Total weighted-average common shares outstanding, basic (in Shares) | |||||
| Weighted-average common shares outstanding, diluted (in Shares) | |||||
| Common stock subject to possible redemption | |||||
| Total weighted-average common shares outstanding, diluted (in Shares) | |||||
Loading...